UNIL088 is a water-soluble prodrug of cyclosporine A (CsA) developed for topical eye delivery. Such a prodrug has to fulfil two paradoxical requirements as it must be rapidly hydrolysed under physiological conditions but also retain a long shelf-life in aqueous media. This study has been conducted to explore the stability of UNIL088 formulated as an eyedrop solution. The stability study of the prodrug was performed over a pH range of 5–7 at 20 ◦C and at various ionic strengths. The molecule was more stable at pH 5 than at pH 7 with conversion rate constant of 3.2 × 10−3 a was determi solubility,
Purpose Results of an evaluation of the physical and chemical stability of extemporaneously prepared...
The objective of this research was to explore two formulation strategies—hydrotropic solubilization ...
Glaucoma is a wide-spread eye disease caused by elevated intraocular pressure. Uncontrolled, this pr...
The purpose of this study is to demonstrate that a novel water-soluble prodrug of cyclosporine A (Cs...
Cyclosporine A (CsA) has been demonstrated to be effective for the treatment of a variety of ophthal...
Cyclosporine A (CsA) has been demonstrated to be effective for the treatment of a variety of ophthal...
The aim of this study was to evaluate the rate and mechanism of conversion of two water-soluble prod...
Cyclosporine A is a poorly water-soluble, immunosuppressive drug used to treat a variety of ocular d...
Cyclosporine A is a poorly water-soluble, immunosuppressive drug used to treat a variety of ocular d...
UNIL088 is a water-soluble prodrug of cyclosporine A (CsA) designed for topical ocular delivery. The...
International audienceCyclosporine A eye drops are used at concentrations ranging from 0.5 to 20 mg/...
International audienceCyclosporine A eye drops are used at concentrations ranging from 0.5 to 20 mg/...
International audienceTacrolimus is an immunosuppressant used to treat a large variety of inflammato...
International audienceTacrolimus is an immunosuppressant used to treat a large variety of inflammato...
Tacrolimus is an immunosuppressant used to treat a large variety of inflammatory or immunity-mediate...
Purpose Results of an evaluation of the physical and chemical stability of extemporaneously prepared...
The objective of this research was to explore two formulation strategies—hydrotropic solubilization ...
Glaucoma is a wide-spread eye disease caused by elevated intraocular pressure. Uncontrolled, this pr...
The purpose of this study is to demonstrate that a novel water-soluble prodrug of cyclosporine A (Cs...
Cyclosporine A (CsA) has been demonstrated to be effective for the treatment of a variety of ophthal...
Cyclosporine A (CsA) has been demonstrated to be effective for the treatment of a variety of ophthal...
The aim of this study was to evaluate the rate and mechanism of conversion of two water-soluble prod...
Cyclosporine A is a poorly water-soluble, immunosuppressive drug used to treat a variety of ocular d...
Cyclosporine A is a poorly water-soluble, immunosuppressive drug used to treat a variety of ocular d...
UNIL088 is a water-soluble prodrug of cyclosporine A (CsA) designed for topical ocular delivery. The...
International audienceCyclosporine A eye drops are used at concentrations ranging from 0.5 to 20 mg/...
International audienceCyclosporine A eye drops are used at concentrations ranging from 0.5 to 20 mg/...
International audienceTacrolimus is an immunosuppressant used to treat a large variety of inflammato...
International audienceTacrolimus is an immunosuppressant used to treat a large variety of inflammato...
Tacrolimus is an immunosuppressant used to treat a large variety of inflammatory or immunity-mediate...
Purpose Results of an evaluation of the physical and chemical stability of extemporaneously prepared...
The objective of this research was to explore two formulation strategies—hydrotropic solubilization ...
Glaucoma is a wide-spread eye disease caused by elevated intraocular pressure. Uncontrolled, this pr...